Cargando…

Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis

BACKGROUND: Recent reports have described decreased effectiveness of teicoplanin in the treatment of bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA) with teicoplanin minimal inhibitory concentration (MIC) ≥1.5 mg/L. Consensus guidelines recommend considering use of alternative a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Ching-Yen, Lee, Chen-Hsiang, Chen, I-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208792/ https://www.ncbi.nlm.nih.gov/pubmed/30464543 http://dx.doi.org/10.2147/IDR.S184411

Ejemplares similares

Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality
por: Hsieh, Yu-Chia, et al.
Publicado: (2016)

Prognosis of patients with methicillin-resistant Staphylococcus aureus bloodstream infection treated with teicoplanin: a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations
por: Wang, Jann-Tay, et al.
Publicado: (2013)

408 The Comparison of in-vitro Activity of Daptomycin with Vancomycin and Teicoplanin against Methicillin-Resistant Staphylococcus aureus Strains Isolated from Bloodstream Infections
por: Demirdal, Tuna, et al.
Publicado: (2014)

Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis
por: Watanabe, Shinichi, et al.
Publicado: (2019)

Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2021)

Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2018)

In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
por: Xu, Yanlei, et al.
Publicado: (2021)

Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
por: Wu, Wei, et al.
Publicado: (2021)

Immobilised teicoplanin does not demonstrate antimicrobial activity against Staphylococcus aureus
por: Britton, S., et al.
Publicado: (2022)

Activities of vancomycin, teicoplanin and linezolid against bacteraemic methicillin-resistant Staphylococcus aureus strains in Gauteng, South Africa
por: Botha, ME, et al.
Publicado: (2009)

Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Lee, Jang Ho, et al.
Publicado: (2022)

Teicoplanin Dosing Strategy for Treatment of Staphylococcus aureus in Korean Patients with Neutropenic Fever
por: Ahn, Byung-Jin, et al.
Publicado: (2011)

Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin
por: Gonçalves, Fábio D. A., et al.
Publicado: (2016)

Efficacy of Linezolid, Teicoplanin, and Vancomycin in Prevention of an Experimental Polytetrafluoroethylene Graft Infection Model caused by Methicillin-Resistant Staphylococcus aureus
por: Mese, Bulent, et al.
Publicado: (2015)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions
por: Parra, Diego, et al.
Publicado: (2015)

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2019)

Teicoplanin associated gene tcaA inactivation increases persister cell formation in Staphylococcus aureus
por: Habib, Gul, et al.
Publicado: (2023)

Research into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at common doses added to bone cement
por: Kılınç, Seyran, et al.
Publicado: (2020)

Teicoplanin pharmacokinetics during albumin dialysis
por: Weiler, Stefan, et al.
Publicado: (2010)

Is Therapeutic Drug Monitoring of Teicoplanin Useful?
por: Kim, Shin-Woo
Publicado: (2014)

2452. Treatment and Outcomes of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Hadid, Hind, et al.
Publicado: (2018)

Comparison of teicoplanin disk diffusion and broth microdilution methods against clinical isolates of Staphylococcus aureus and S. epidermidis
por: Camargo, Carlos Henrique, et al.
Publicado: (2011)

Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration
por: Peeters, Olivier, et al.
Publicado: (2016)

1222. Risk Factors and Outcomes for Daptomycin Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Hadid, Hind, et al.
Publicado: (2018)

Therapeutic Drug Concentrations of Teicoplanin in Clinical Settings
por: Nah, So-Yun, et al.
Publicado: (2014)

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
por: Ramos-Martín, V., et al.
Publicado: (2017)

Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin
por: Bereczki, Ilona, et al.
Publicado: (2020)

Teicoplanin: an alternative drug for the treatment of COVID-19?
por: Baron, Sophie Alexandra, et al.
Publicado: (2020)

Clinical outcomes of teicoplanin use in the OPAT setting
por: Dabrowski, Hannah, et al.
Publicado: (2020)

The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
por: Bereczki, Ilona, et al.
Publicado: (2022)

Vascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat model
por: Atahan, Erhan, et al.
Publicado: (2009)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
por: San-Juan, Rafael, et al.
Publicado: (2016)

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Zasowski, Evan J, et al.
Publicado: (2021)

Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
por: Parlato, Ciro, et al.
Publicado: (2011)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

A Case of Hypersensitivity Syndrome to Both Vancomycin and Teicoplanin
por: Kwon, Hyouk-Soo, et al.
Publicado: (2006)

An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
por: De Burghgraeve, Tine, et al.
Publicado: (2012)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto, Kazuaki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3o8ne0vfv8tes8l8oucb1c51g7